Patents by Inventor Vickas Patel

Vickas Patel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF HDAC INHIBITORS FOR TREATMENT OF CARDIAC RHYTHM DISORDERS
    Publication number: 20190142773
    Abstract: The present invention provides methods of ameliorating or reducing the extent of cardiac arrhythmia disorders, by administering an inhibitor of histone deacetylase enzyme (HDAC).
    Type: Application
    Filed: February 5, 2018
    Publication date: May 16, 2019
    Applicant: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
    Inventors: Vickas PATEL, Jonathan A. EPSTEIN
  • Use of HDAC inhibitors for treatment of cardiac rhythm disorders
    Patent number: 9884031
    Abstract: The present invention provides methods of ameliorating or reducing the extent of cardiac arrhythmia disorders, by administering an inhibitor of histone deacetylase enzyme (HDAC).
    Type: Grant
    Filed: May 7, 2008
    Date of Patent: February 6, 2018
    Assignee: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
    Inventors: Vickas Patel, Jonathan A. Epstein
  • Transcriptome transfer produces cellular phenotype conversion
    Patent number: 9845480
    Abstract: The present invention includes methods for effecting phenotype conversion in a cell by transfecting the cell with phenotype-converting nucleic acid. Expression of the nucleic acids results in a phenotype conversion in the transfected cell. Preferably the phenotype-converting nucleic acid is a transcriptome, and more preferably an mRNA transcriptome.
    Type: Grant
    Filed: October 12, 2015
    Date of Patent: December 19, 2017
    Assignee: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
    Inventors: James Eberwine, Jai-Yoon Sul, Tae Kyung Kim, Vickas Patel
  • Transcriptome Transfer Produces Cellular Phenotype Conversion
    Publication number: 20160046958
    Abstract: The present invention includes methods for effecting phenotype conversion in a cell by transfecting the cell with phenotype-converting nucleic acid. Expression of the nucleic acids results in a phenotype conversion in the transfected cell. Preferably the phenotype-converting nucleic acid is a transcriptome, and more preferably an mRNA transcriptome.
    Type: Application
    Filed: October 12, 2015
    Publication date: February 18, 2016
    Inventors: James Eberwine, Jai-Yoon Sul, Tae Kyung Kim, Vickas Patel
  • Transcriptome transfer produces cellular phenotype conversion
    Patent number: 9157066
    Abstract: The present invention includes methods for effecting phenotype conversion in a cell by transfecting the cell with phenotype-converting nucleic acid. Expression of the nucleic acids results in a phenotype conversion in the transfected cell. Preferably the phenotype-converting nucleic acid is a transcriptome, and more preferably an mRNA transcriptome.
    Type: Grant
    Filed: July 19, 2011
    Date of Patent: October 13, 2015
    Assignee: The Trustees of the University of Pennsylvania
    Inventors: James Eberwine, Jai-Yoon Sul, Tae Kyung Kim, Vickas Patel
  • Transcriptome Transfer Produces Cellular Phenotype Conversion
    Publication number: 20120129261
    Abstract: The present invention includes methods for effecting phenotype conversion in a cell by transfecting the cell with phenotype-converting nucleic acid. Expression of the nucleic acids results in a phenotype conversion in the transfected cell. Preferably the phenotype-converting nucleic acid is a transcriptome, and more preferably an mRNA transcriptome.
    Type: Application
    Filed: July 19, 2011
    Publication date: May 24, 2012
    Inventors: James Eberwine, Jai-Yoon Sul, Tai Kyung Kim, Vickas Patel
  • USE OF HDAC INHIBITORS FOR TREATMENT OF CARDIAC RHYTHM DISORDERS
    Publication number: 20100298237
    Abstract: The present invention provides methods of ameliorating or reducing the extent of cardiac arrhythmia disorders, by administering an inhibitor of histone deacetylase enzyme (HDAC).
    Type: Application
    Filed: May 7, 2008
    Publication date: November 25, 2010
    Inventors: Vickas Patel, Jonathan A. Epstein